Advocating for a world where intellectual
property law serves the public interest.
WTO negotiators have agreed to extend a moratorium on “non-violation and situation” complaints under the organisation’s intellectual property rules for an additional two years, forwarding the planned decision to the global trade body’s upcoming ministerial conference for adoption. The news comes as WTO members continue discussing the extension of another moratorium on customs duties on […]
[Ernesto for TorrentFreak, Link (CC-BY)] The German Supreme Court has opened the door for ISP blockades of copyright infringing sites. In a landmark decision the court ruled that ISPs can be required to block websites if copyright holders fail to identify their operators or hosting providers. Domain name blocking has become one of the entertainment […]
This article is part of an IP-Watch and Infojustice.org series analyzing the Trans Pacific Partnership intellectual property provisions by leading experts around the world. The series will publish weekly through the first quarter of 2016. During the negotiation of the Trans-Pacific Partnership Agreement, many concerns were voiced about how TPP would mandate adoption of U.S. […]
[Software Freedom Law Center, Link (CC-BY-SA)] The first official public release of the text of the Trans-Pacific Partnership Trade Agreement (known universally as the TPP) on November 5, 2015 generated much heated speculation. The ideal of “open agreements, openly arrived at” remains regrettably unattainable in international affairs. “Fast track” trade negotiating authority in the US […]
This article is part of an IP-Watch and Infojustice.org series analyzing the Trans Pacific Partnership intellectual property provisions by leading experts around the world. The series will publish weekly through the first quarter of 2016. Section J of the TPP’s IP chapter, on ISP safe harbors, looks a lot like Section 512 of the DMCA, […]
The royalty-free agreement allows manufacturers to develop daclatasvir for 112 low- and middle-income countries [MPP Press Release, Link (CC-BY-NC-ND] The Medicines Patent Pool (MPP) today announced its first licence for a hepatitis C medicine, signing an agreement with Bristol-Myers Squibb for daclatasvir, a novel direct-acting antiviral that is proven to help cure multiple genotypes of […]
Posts by Category
- Video
- User Rights Network
- US Domestic Policies
- US Domestic Legislation
- Transparency
- Trade Agreements
- Takedown
- Trade Disputes
- Trademark
- Round-up
- Regional Fora
- Surveys and Data
- Positive Agenda
- Patent Pledges
- Open
- News
- Multilateral Fora
- Limitations and Exceptions
- IP & Research
- IP and Human Rights
- Industry Initiatives
- Flagged
- Fair Use
- Events
- Empirical Research
- Document Library
- Coronavirus
- Brazil
- Blog
- Bilateral Trade Pressures
- Artificial Intelligence
- AI
- Africa Group Work Plan Proposal
- Africa: Copyright & Public Interest
- Access to Medicine
- Academic Resources